Application 210054

Type
ANDA
Sponsor
AJANTA PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RANOLAZINERANOLAZINETABLET, EXTENDED RELEASE;ORAL500MGNoNo
002RANOLAZINERANOLAZINETABLET, EXTENDED RELEASE;ORAL1GMNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
27241-125RanolazineRanolazineAjanta Pharma LimitedANDACurrent
27241-125RanolazineRanolazineAjanta Pharma LimitedANDACurrent
27241-125RanolazineRanolazineAjanta Pharma LimitedANDACurrent
27241-125RanolazineRanolazineAjanta Pharma LimitedANDACurrent
27241-125RanolazineRanolazineAjanta Pharma USA Inc.ANDACurrent
27241-126RanolazineRanolazineAjanta Pharma LimitedANDACurrent
27241-126RanolazineRanolazineAjanta Pharma LimitedANDACurrent
27241-126RanolazineRanolazineAjanta Pharma LimitedANDACurrent
27241-126RanolazineRanolazineAjanta Pharma LimitedANDACurrent
27241-126RanolazineRanolazineAjanta Pharma USA Inc.ANDACurrent
60687-549RanolazineRanolazineAmerican Health PackagingANDACurrent
60687-549RanolazineRanolazineAmerican Health PackagingANDACurrent